M&A Report

Exact Sciences Makes a Bold Double Play to Bolster Its Early Cancer Detection Capabilities

Although volume was light, October was a robust month for M&A deal making in terms of impact, especially in the cancer diagnostics space. The month started with the announcement of Invitae’s … [Read more...]

Diagnostics Deals

JetBlue Partners with Vault Health to Offer Travelers At-Home COVID-19 Testing

COVID-19 has greatly complicated air travel from country to country and even state to state. While entrance rules vary from place to place, a number of jurisdictions are allowing travelers to avoid … [Read more...]

M&A Report

Re-Acquisition of Grail to Boost Illumina’s Cancer Presence, but Investors Are Skeptical

M&A activity during the time of COVID-19 has been notable for two and largely incongruous characteristics: scant numbers of overall deals and unexpected, rather curious blockbusters. A month after … [Read more...]

Direct-To-Consumer

Walmart & Quest Provide Drone Delivery of At-Home COVID-19 Test Kits

The previous decade has seen the direct-to-consumer (DTC) diagnostics products business take quantum leaps forward thanks to collaborations between major lab companies and retail giants that enable … [Read more...]

M&A Report

One Blockbuster Dies and Another Arises as Sluggish Deal Making Continues

The decline in diagnostic M&A activity is reflective of what’s been happening across the entire healthcare industry, with deals from down 20% during Q2, as compared to Q1 2020, according to … [Read more...]

Diagnostic Deals

New Study to Evaluate Clinical Effectiveness of CRISPR SARS-CoV-2 Testing

The FDA has granted emergency use authorization (EUA) for several different kinds of assays to detect the SARS-CoV-2 virus, including reverse transcription-polymerase chain reaction (PCR), blood-based … [Read more...]

M&A Report

Surging Demand for COVID-19 Testing Forces Thermo Fisher to Raise Its Offer for Qiagen

Back in March, Thermo Fisher Scientific announced that it had agreed to acquire Qiagen for $11.5 billion. At the time, the €39 (roughly $46) per share representing a premium of 23 percent over the … [Read more...]

Diagnostics Deals

3M and MIT Team Up to Create Rapid, Scalable SARS-CoV-2 Antigen Test

Unlike reverse transcription-polymerase chain reaction (PCR) and blood-based serology antibody assays, antigen tests are relatively inexpensive to produce and generate results rapidly at the point of … [Read more...]

Inside the Lab Industry 

Humana, LabCorp, Quest and Walmart Partner on At-Home & Drive-Thru COVID-19 Testing

Humana is teaming up with the country’s biggest retailer and two biggest testing labs to make it easier for members to get COVID-19 testing in non-traditional diagnostics settings. First, the national … [Read more...]

Diagnostics Deals

Global Non-Profit & Smartphone DX Firm to Create Malaria Diagnosis App

Malaria continues to wreak havoc around the world, particularly in low- and middle-income countries (LMICs). Although rapid in vitro diagnostic tests (RDTs) for malaria are widely used in those … [Read more...]


(-00000g2)